152 related articles for article (PubMed ID: 37953391)
21. Does whole-body Patlak
Fahrni G; Karakatsanis NA; Di Domenicantonio G; Garibotto V; Zaidi H
Eur Radiol; 2019 Sep; 29(9):4812-4821. PubMed ID: 30689031
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the normal adrenal gland with 18F-FDG PET/CT.
Bagheri B; Maurer AH; Cone L; Doss M; Adler L
J Nucl Med; 2004 Aug; 45(8):1340-3. PubMed ID: 15299059
[TBL] [Abstract][Full Text] [Related]
23. Image Quality and Quantitative PET Parameters of Low-Dose [
Calderón E; Schmidt FP; Lan W; Castaneda-Vega S; Brendlin AS; Trautwein NF; Dittmann H; la Fougère C; Kiefer LS
Diagnostics (Basel); 2023 Oct; 13(20):. PubMed ID: 37892061
[TBL] [Abstract][Full Text] [Related]
24. Simulated Reduced-Count Whole-Body FDG PET: Evaluation in Children and Young Adults Imaged on a Digital PET Scanner.
Alves VPV; Brady S; Ata NA; Li Y; MacLean J; Zhang B; Sharp SE; Trout AT
AJR Am J Roentgenol; 2022 Dec; 219(6):952-961. PubMed ID: 35731102
[No Abstract] [Full Text] [Related]
25. An exploration of the feasibility and clinical value of half-dose 5-h total-body
Adili D; Cai D; Wu B; Yu H; Gu Y; Zhang Y; Shi H
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2375-2385. PubMed ID: 36864361
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of quantitative imaging parameters in head and neck squamous cell carcinoma.
Gupta T; Chatterjee A; Rangarajan V; Purandare N; Arya S; Murthy V; Budrukkar A; Ghosh-Laskar S; Agarwal JP
Q J Nucl Med Mol Imaging; 2022 Jun; 66(2):162-170. PubMed ID: 31496204
[TBL] [Abstract][Full Text] [Related]
27. Quantitative classification and radiomics of [
de Koster EJ; Noortman WA; Mostert JM; Booij J; Brouwer CB; de Keizer B; de Klerk JMH; Oyen WJG; van Velden FHP; de Geus-Oei LF; Vriens D;
Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2174-2188. PubMed ID: 35138444
[TBL] [Abstract][Full Text] [Related]
28. Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size.
Kurland BF; Muzi M; Peterson LM; Doot RK; Wangerin KA; Mankoff DA; Linden HM; Kinahan PE
J Nucl Med; 2016 Feb; 57(2):226-30. PubMed ID: 26493206
[TBL] [Abstract][Full Text] [Related]
29. Treatment monitoring by 18F-FDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors.
Benz MR; Evilevitch V; Allen-Auerbach MS; Eilber FC; Phelps ME; Czernin J; Weber WA
J Nucl Med; 2008 Jul; 49(7):1038-46. PubMed ID: 18552153
[TBL] [Abstract][Full Text] [Related]
30. FDG imaging with long-axial field-of-view PET/CT in patients with high blood glucose-a matched pair analysis.
Mingels C; Weissenrieder L; Zeimpekis K; Sari H; Nardo L; Caobelli F; Alberts I; Rominger A; Pyka T
Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):2036-2046. PubMed ID: 38383743
[TBL] [Abstract][Full Text] [Related]
31. Relationships of body habitus and SUV indices with signal-to-noise ratio of hepatic (18)F-FDG PET.
Keramida G; Dunford A; Siddique M; Cook GJ; Peters AM
Eur J Radiol; 2016 May; 85(5):1012-5. PubMed ID: 27130064
[TBL] [Abstract][Full Text] [Related]
32.
Singh I; Bikas A; Garcia CA; Desale S; Wartofsky L; Burman KD
Endocr Pract; 2017 Feb; 23(2):182-189. PubMed ID: 27849386
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study.
Vera P; Bohn P; Edet-Sanson A; Salles A; Hapdey S; Gardin I; Ménard JF; Modzelewski R; Thiberville L; Dubray B
Radiother Oncol; 2011 Jan; 98(1):109-16. PubMed ID: 21056487
[TBL] [Abstract][Full Text] [Related]
34.
Calabro' A; Abdelhafez YG; Triumbari EKA; Spencer BA; Chen MS; Albano D; Cassim CR; Bertagna F; Dondi F; Cherry SR; Badawi RD; Sen F; Nardo L
BMC Med Imaging; 2023 Jan; 23(1):9. PubMed ID: 36627570
[TBL] [Abstract][Full Text] [Related]
35. Quantitative FDG PET/CT in the community: experience from interpretation of outside oncologic PET/CT exams in referred cancer patients.
Tahari AK; Wahl RL
J Med Imaging Radiat Oncol; 2014 Apr; 58(2):183-8. PubMed ID: 24314055
[TBL] [Abstract][Full Text] [Related]
36. Automated detection, delineation and quantification of whole-body bone metastasis using FDG-PET/CT images.
Nigam R; Field M; Harris G; Barton M; Carolan M; Metcalfe P; Holloway L
Phys Eng Sci Med; 2023 Jun; 46(2):851-863. PubMed ID: 37126152
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
38. Ferumoxytol Does Not Impact Standardized Uptake Values on PET/MR Scans.
Muehe AM; Yerneni K; Theruvath AJ; Thakor AS; Pribnow A; Avedian R; Steffner R; Rosenberg J; Hawk KE; Daldrup-Link HE
Mol Imaging Biol; 2020 Jun; 22(3):722-729. PubMed ID: 31325083
[TBL] [Abstract][Full Text] [Related]
39. Comparison of image quality between step-and-shoot and continuous bed motion techniques in whole-body
Yamashita S; Yamamoto H; Nakaichi T; Yoneyama T; Yokoyama K
Ann Nucl Med; 2017 Nov; 31(9):686-695. PubMed ID: 28815414
[TBL] [Abstract][Full Text] [Related]
40. Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from
Schmidkonz C; Krumbholz M; Atzinger A; Cordes M; Goetz TI; Prante O; Ritt P; Schaefer C; Agaimy A; Hartmann W; Rössig C; Fröhlich B; Bäuerle T; Dirksen U; Kuwert T; Metzler M
Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1564-1575. PubMed ID: 31853559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
